Importantly, in lung cancer MAP3K3 is not involved in the ERK1/2 pathway which was reported in T cell or breast cancer26, 29 or the MAPK7 (ERK5)45 pathway, potentially reflecting tissue specificity. Here, MAP3K3 is linked to lung carcinoma.